Optimum Investment Advisors Geron Corp Transaction History

Optimum Investment Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$0.98 - $1.85 $1,960 - $3,700	-2,000 Closed	0 $0
Q3 2018 Oct 05, 2018	SELL	$1.76 - $6.38 $7,920 - $28,710	-4,500 Reduced 69.23%	2,000 $4,000
Q1 2018 May 09, 2018	BUY	$1.81 - $5.98 $11,765 - $38,870	6,500 New	6,500 $28,000
Q3 2017 Nov 21, 2017	SELL	$1.99 - $2.65 $23,880 - $31,800	-12,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	12,000	12,000 $33,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.